Clonal Hematopoiesis of Indeterminate Potential With Loss of <i>Tet2</i> Enhances Risk for Atrial Fibrillation Through <i>Nlrp3</i> Inflammasome Activation
Amy E. Lin(Brigham and Women's Hospital), Benjamin L. Ebert(Dana-Farber Cancer Institute), Christopher J. Farady(Novartis (Switzerland)), Abhishek Niroula(Broad Institute), Jiangchuan Ye(Broad Institute), Veronica Shkolnik(Dana-Farber Cancer Institute), Patricio Flores-Bringas(Broad Institute), Peter Libby(Harvard University), David J. Milan(Broad Institute), Pradeep Natarajan(Unknown), Mridul Agrawal(Dana-Farber Cancer Institute), Aneesh Bapat(Massachusetts General Hospital), Patrick T. Ellinor(Broad Institute), Ling Xiao(Sun Yat-sen University), Andreas Boettcher(Novartis (Switzerland)), Christopher A. Hergott(Brigham and Women's Hospital), Alexander G. Bick(Vanderbilt University Medical Center), Marie McConkey(Dana-Farber Cancer Institute), Waihay J. Wong(Brigham and Women's Hospital)
Cited by 75
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Analysis of protein-coding genetic variation in 60,706 humans
|Nature|2016|10.3k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Inflammation in Atherosclerosis
|Arteriosclerosis Thrombosis and Vascular Biology|2012|3.7k